Detalhe da pesquisa
1.
Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Mod Pathol
; 37(1): 100352, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839675
2.
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Am J Hematol
; 99(4): 606-614, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342997
3.
Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study.
Oncologist
; 28(5): 462-e303, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36942937
4.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Blood
; 137(13): 1792-1803, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024987
5.
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
Transfusion
; 61(10): 2830-2836, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251040
6.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Blood
; 141(15): 1884-1888, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332187
7.
Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2-ALK fusion.
Am J Hematol
; 98(2): 365-367, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491794
8.
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Br J Haematol
; 169(3): 352-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25612847
9.
Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base.
Cancer Causes Control
; 26(8): 1163-72, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26054914
10.
Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Am J Hematol
; 89(3): 310-4, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273125
11.
Unusual blasts with basophilic granules in 2 cases of de novo acute myeloid leukemia with inv3(q21q26.2) and monosomy 7 and coexpression of CD2 and CD31.
Ann Diagn Pathol
; 18(1): 33-40, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23896391
12.
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Blood Adv
; 8(3): 591-602, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052038
13.
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.
JCO Oncol Pract
; 20(2): 220-227, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683132
14.
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
Cancer
; 119(20): 3672-9, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913575
15.
Cellular immunotherapy for refractory hematological malignancies.
J Transl Med
; 11: 150, 2013 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23782682
16.
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation.
Leuk Res
; 125: 107004, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577290
17.
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
NEJM Evid
; 2(10): EVIDoa2300074, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320179
18.
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates.
Clin Cancer Res
; 29(5): 878-887, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534523
19.
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study.
Lancet Haematol
; 10(4): e272-e283, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990622
20.
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
Leuk Res
; 132: 107351, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451200